CELCUITY INC. Finance Lease, Liability, Current
CELCUITY INC. (CELC) had Finance Lease, Liability, Current of $981 as of 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:FinanceLeaseLiabilityCurrent · last filed 2024-03-27
- 2023-03-31: Finance Lease, Liability, Current $981.00.
- 2022-12-31: Finance Lease, Liability, Current $2.45K.
- 2022-09-30: Finance Lease, Liability, Current $3.92K.
- 2022-06-30: Finance Lease, Liability, Current $5.38K.
| Period end | Finance Lease, Liability, Current |
|---|---|
| 2023-03-31 | $981.00 10-Q · filed 2023-05-15 |
| 2022-12-31 | $2.45K 10-K · filed 2024-03-27 |
| 2022-09-30 | $3.92K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $5.38K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $5.86K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $5.85K 10-K · filed 2023-03-23 |
| 2021-09-30 | $5.84K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $5.83K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $5.82K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $5.81K 10-K · filed 2022-03-23 |
| 2020-06-30 | $5.79K 10-Q/A · filed 2020-08-11 |
| 2020-03-31 | $5.78K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $5.77K 10-K · filed 2021-02-16 |
| 2019-09-30 | $5.76K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $5.75K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $5.74K 10-Q · filed 2019-05-07 |
| 2018-12-31 | $5.73K 10-K · filed 2020-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |